Human_JJ
15-lipoxygenase_NN
gene_NN
promoter_NN
:_:
analysis_NN
and_CC
identification_NN
of_IN
DNA_NN
binding_NN
sites_NNS
for_IN
IL-13-induced_JJ
regulatory_JJ
factors_NNS
in_IN
monocytes_NNS
._.

In_IN
order_NN
to_TO
study_VB
the_DT
transcriptional_JJ
control_NN
of_IN
15-LO_NN
expression_NN
,_,
we_PRP
have_VBP
cloned_VBN
and_CC
sequenced_VBD
the_DT
human_JJ
15-LO_NN
promoter_NN
region_NN
._.

The_DT
15-LO_NN
promoter_NN
is_VBZ
associated_VBN
with_IN
a_DT
CpG_NN
island_NN
at_IN
the_DT
5_CD
'_POS
-_:
end_NN
of_IN
the_DT
gene_NN
,_,
and_CC
sequence_NN
analysis_NN
reveals_VBZ
putative_JJ
Sp1_NN
and_CC
Ap2_NN
binding_NN
site\/s_NNS
and_CC
absence_NN
of_IN
TATA_NN
or_CC
CAAT_NN
motifs_NNS
._.

Transcription_NN
is_VBZ
initiated_VBN
at_IN
one_CD
major_JJ
site_NN
._.

Using_VBG
deletion_NN
constructs_NNS
,_,
we_PRP
have_VBP
defined_VBN
an_DT
active_JJ
promoter_NN
region_NN
of_IN
1056_CD
bp_NN
._.

Gel-shift_JJ
assays_NNS
revealed_VBD
that_IN
transcriptional_JJ
factor_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
induced_VBN
only_RB
in_IN
response_NN
to_TO
IL-13_NN
treatment_NN
of_IN
human_JJ
peripheral_JJ
blood_NN
monocytes_NNS
bind_VBP
to_TO
the_DT
15-LO_NN
promoter_NN
DNA_NN
._.

Two_CD
regions_NNS
,_,
DP1_NN
-LRB-_-LRB-
-140_CD
to_TO
-92_CD
bp_NN
-RRB-_-RRB-
and_CC
DP2_NN
-LRB-_-LRB-
-353_CD
to_TO
-304_CD
bp_NN
-RRB-_-RRB-
of_IN
the_DT
promoter_NN
were_VBD
essential_JJ
for_IN
transcription_NN
in_IN
HeLa_NN
cells_NNS
and_CC
human_JJ
peripheral_JJ
monocytes_NNS
._.

Hela_NN
nuclear_JJ
extracts_NNS
contained_VBD
a_DT
specific_JJ
nuclear_JJ
factor_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
binding_NN
to_TO
15-LO_NN
promoter_NN
DNA_NN
which_WDT
are_VBP
distinct_JJ
from_IN
those_DT
derived_VBN
from_IN
IL-13-treated_JJ
human_JJ
peripheral_JJ
monocyte_NN
nuclear_JJ
extracts_NNS
._.

In_IN
addition_NN
,_,
fluorescent_JJ
in_FW
situ_FW
hybridization_NN
-LRB-_-LRB-
FISH_NN
-RRB-_-RRB-
results_NNS
refined_VBD
the_DT
previous_JJ
localization_NN
of_IN
15-LO_NN
to_TO
human_JJ
chromosome_NN
17p13_NN
.3_NN
._.

